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Background
Type three diabetes is a term recently coined to unveil the link 
between type 2 diabetes mellitus (T2DM) and dementia, specifically 
Alzheimer’s Disease (AD). In 2015,1 type 2 diabetes was the sixth 
leading cause of disability in the United States. It is characterized by 
unusually high levels of glucose in the blood.2 The etiology of T2DM is 
largely due to insulin resistance combined with disturbance in the key 
role of insulin producing beta cells.2-5 Alzheimer’s disease is the most 
common form of dementia and becomes worse over time.6,7 Brain 
glucose metabolism is reduced in AD and glucose metabolism is also 
impaired in cells as an epidemiological characteristic of T2DM.8 There 
is a growing interest to study the link between these two diseases.
Objectives 
The object of this systematic review is to investigate the following 
research question: How are patients with type 2 diabetes mellitus at 
an increased risk for dementia, such as Alzheimer’s Disease, compared 
to patients without diabetes? This review examined the link between 
these two disease.
Study Design
A systematic review was conducted by searching electronic databases of current literature, published from 
January 2010 to January 2019, using the PRISMA Protocol. Articles that met the criteria (subjects >18 years old) 
were selected by one reviewer. Electronic databases (PubMed, Cochrane, Proquest, Scopus, PsycInfo, and 
SocInfo) were used to find articles with key search words: “Dementia + Type 2 Diabetes Mellitus” OR 
“Alzheimer’s Disease + Type 2 Diabetes Mellitus.” Nine studies were used in this systematic review. 
Results
In this systematic review, the results show a positive association between type 2 diabetes mellitus in mid-life 
and later dementia, such as Alzheimer’s Disease.8-13 At the cellular level insulin unlocks the cells’ ability to 
metabolize glucose. In type two diabetes mellitus, insulin is resisted by the cell which leaves glucose roaming 
the blood with no where to go.1-5 Likewise, the metabolism of glucose in the human brain is completely 
dependent on insulin.14 In the event where no insulin is present, glucose, which is an energy source for the 
neurons, can not be used and the neurons begin to degenerate. 6,7,10, This degeneration leads to cell death of 
the neuron; as a result, cognitive and memory functions are impaired and lead to Alzheimer’s Disease.8-16
Conclusions:
This systematic review explains the relationship between type 2 
diabetes mellitus and the formation of Alzheimer’s disease. This 
review also indicates how those with type 2 diabetes mellitus are at 
an increased risk of Alzheimer’s disease because of the metabolic 
problems of insufficient insulin for cells; this prevents the uptake of 
glucose in cells, as seen in the neurons of the brain. Further study 
into oxidative stress will be necessary to clarify the etiology of type 
2 diabetes mellitus along with Alzheimer’s disease. 
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